Pomerantz LLP is investigating claims on behalf of investors of  Laser Photonics Corporation ("Laser Photonics" or the "Company") .  Such investors are advised to contact Danielle Peyton at ...

The company is one of the first to receive a “platform technology designation,” which could speed the review of certain gene ...

A quality improvement strategy can improve electronic health record-based screening for depression and anxiety in people with ...

Biohaven Ltd. will present an investor presentation detailing its ongoing and planned trials for various development programs, including troriluzole, taldefgrobep ...

DelveInsight's Major Depressive Disorder pipeline report depicts a robust space with 75+ active players working to develop ...

Individuals living near golf courses, as well as those who reside in water service areas that include golf courses, are at ...

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

The Spinocerebellar Ataxia pipeline is advancing fast as troriluzole nears FDA nod and rivals race with gene and stem cell therapies to seize market edge. Disease modification in spinocerebellar ...

We recently published a list of Jim Cramer’s Thoughts on These 10 Stocks. In this article, we are going to take a look at ...

Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor.